Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grand Brilliance Group HoldingsHKSE:08372 66 PB Ratio is 0.87 as of Aug. 09, 2026, which is 14% above its 10-year median of 0.76. GuruFocus rates HKSE:08372 with a GF Score™ of 66/100 and a GF Value™ of HK$0.12 (Fairly Valued). The stock has 5 warning signs investors should review. Among 113 Medical Distribution companies, Grand Brilliance Group Holdings ranks better than 63.72% on this metric.
The historical rank and industry rank for Grand Brilliance Group Holdings's PB Ratio or its related term are showing as below:
HKSE:08372'
s PB Ratio Range Over the Past 10 Years
Min: 0.53 Med: 0.76 Max: 10.26
Current: 0.87
During the past 11 years, Grand Brilliance Group Holdings's highest PB Ratio was 10.26. The lowest was 0.53. And the median was 0.76.
HKSE:08372's PB Ratio is ranked better than 63.72% of 113
companies
in the Medical Distribution industry
Industry Median: 1.02
vs HKSE:08372: 0.87
During the past 12 months, Grand Brilliance Group Holdings's average Book Value Per Share Growth Rate was 5.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.50% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Grand Brilliance Group Holdings was 41.70% per year. The lowest was 3.50% per year. And the median was 5.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Grand Brilliance Group Holdings PB Ratio Related Terms
Grand Brilliance Group Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Grand Brilliance Group Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Brilliance Group Holdings PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Grand Brilliance Group Holdings's PB Ratio falls into.
Grand Brilliance Group Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Grand Brilliance Group Holdings (HKSE:08372) has a PB Ratio of 0.87 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grand Brilliance Group Holdings and its competitors. This is 14% above median its historical median of 0.76. Over the past decade, Grand Brilliance Group Holdings' PB Ratio has ranged from 0.53 to 10.26. According to the industry distribution chart, Grand Brilliance Group Holdings ranks #41 out of 113 companies in the Medical Distribution industry, placing it in the top 36.3%.
Is Grand Brilliance Group Holdings' PB Ratio too high?
Grand Brilliance Group Holdings' current PB Ratio of 0.87 is 14% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 10.26. The Medical Distribution industry median PB Ratio is 1.02. Grand Brilliance Group Holdings' value of 0.87 is 14.7% below this industry median. Based on the distribution chart, Grand Brilliance Group Holdings ranks #41 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Grand Brilliance Group Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grand Brilliance Group Holdings' PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Grand Brilliance Group Holdings ranks #41 out of 113 companies for PB Ratio. This puts Grand Brilliance Group Holdings in the upper half of its industry. The industry median PB Ratio is 1.02. Grand Brilliance Group Holdings' value of 0.87 is 14.7% below this benchmark. Historically, Grand Brilliance Group Holdings' own PB Ratio has ranged from 0.53 to 10.26 over the past decade. While the company's 10-year median is 0.76 vs. the industry median of 1.02, Grand Brilliance Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.02, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Brilliance Group Holdings's current PB Ratio of 0.87 is 14.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grand Brilliance Group Holdings and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Brilliance Group Holdings's current PB Ratio is 0.87, which is 14% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Brilliance Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings (HKSE:08372) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.13 — trading 5.8% above its estimated fair value. The current PB Ratio is 0.87, which is 14% above median its 10-year median of 0.76 and 14.7% below the Medical Distribution industry median of 1.02. Grand Brilliance Group Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Grand Brilliance Group Holdings (HKSE:08372), the current PB Ratio is 0.87 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grand Brilliance Group Holdings (HKSE:08372) Overvalued in 2026?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 5.8% above its estimated GF Value™ of HK$0.12.
GuruFocus considers Grand Brilliance Group Holdings to be Fairly Valued.
Key valuation signals for HKSE:08372:
PB Ratio: 0.87 (14% above median its 10-year median of 0.76)
GF Value™: HK$0.12 vs. price of HK$0.13 (5.8% above fair value)
Industry Position: 14.7% below the Medical Distribution median (#41 of 113)
No single metric tells the full story. See the HKSE:08372 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. It serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
66GF Score
Get the complete analysis for HKSE:08372
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08372 has been successfully added to your 
